Monitoring
The purpose of reimbursement monitoring is a constant follow-up on new legal regulations within the reimbursement scope and to gain supplementing information on the status of subsidized drugs within the WiRKliR database. We will monitor websites of specific institutions (for more details please see the report 0 – “Reimbursement monitoring” chapter). It is also crucial to include all the information on WiRKliR database drugs which cannot be found on websites nevertheless can potentially have an impact on reimbursement decisions. In order to gain this kind of public information respective institutions will be contacted directly. Another source of information is patients’ complaints.
